Get the Stockscreener App
1.365
2.50%
-0.035
Vivani Medical Inc stock is traded at $1.365, with a volume of 61,351.
It is down -2.50% in the last 24 hours and up +3.41% over the past month.
Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.
See More
Previous Close:
$1.40
Open:
$1.4
24h Volume:
61,351
Relative Volume:
0.14
Market Cap:
$122.78M
Revenue:
-
Net Income/Loss:
$-27.09M
P/E Ratio:
-3.3821
EPS:
-0.4036
Net Cash Flow:
$-26.52M
1W Performance:
-3.19%
1M Performance:
+3.41%
6M Performance:
+8.33%
1Y Performance:
+9.20%
1-Day Range:
$1.36
$1.40
1-Week Range:
$1.31
$1.43
52-Week Range:
$0.9228
$1.92
Vivani Medical Inc Stock (VANI) Company Profile
Name
Vivani Medical Inc
Sector
Industry
Phone
415-506-8462
Address
1350 S. LOOP ROAD, ALAMEDA
Compare VANI vs VRTX, REGN, ARGX, RVMD, ONC
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VANI
Vivani Medical Inc
|
1.3611 | 126.28M | 0 | -27.09M | -26.52M | -0.4036 |
VRTX
Vertex Pharmaceuticals Inc
|
515.44 | 128.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
806.90 | 82.72B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
992.82 | 53.26B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
215.68 | 43.66B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
362.27 | 39.31B | 5.76B | 514.49M | 1.10B | 4.4813 |
Vivani Medical Inc Stock (VANI) Latest News
Form 8K Vivani Medical Inc For: 17 August By Investing.com - Investing.com Canada
Vivani Medical posts slide presentation under Reg FD; Exhibit 99.1 attached - TradingView
Wall Street Zen Upgrades Vivani Medical (NASDAQ:VANI) to "Hold" - MarketBeat
Vivani Medical (NASDAQ: VANI) Completes Full Enrollment In Semaglutide Implant Trial, Strikes Novo Nordisk Deal - foreignpolicyjournal.com
Vivani Medical Fully Enrolls Phase 1 Semaglutide Implant Trial; Data Due November - Minichart
Form 8K Vivani Medical Inc For: 13 August By Investing.com - Investing.com Nigeria
Vivani Medical (NASDAQ:VANI) Releases Quarterly Earnings Results, Beats Estimates By $0.01 EPS - MarketBeat
Vivani Medical Q2 Results: EPS beats estimate, losses narrow 41% YoY - scanx.trade
Vivani Medical: Q2 Earnings Snapshot - AOL.com
Vivani Medical Inc reports results for the quarter ended June 30Earnings Summary - TradingView
20 Participants Dosed in Semaglutide Trial; Data Due in November - Stock Titan
Vivani Medical (VANI) widens GLP‑1 pipeline, funds runway into Q2 2027 - Stock Titan
ClearOne (CLRO) details Cortigent reverse merger, 78% Vivani control and new equity plan - Stock Titan
ClearOne to merge with Cortigent, pivoting to neurotech under new Nasdaq ticker - Dealroom
Vivani Medical Inc expected to post a loss of 8 cents a shareEarnings Preview - TradingView
ClearOne Inc. (CLRO) majority holder cancels warrant as Cortigent merger proceeds - Stock Titan
Form 8K Vivani Medical Inc For: 6 August By Investing.com - Investing.com Nigeria
Vivani Medical Completes Enrollment, Dosing in Phase 1 SLIM-1 Trial - marketscreener.com
Vivani Completes Enrollment in SLIM-1 Semaglutide Implant Trial - TipRanks
Form 8K Vivani Medical Inc For: 6 August - Investing.com India
Semaglutide implant trial doses all 20 participants; data expected in November - Stock Titan
ClearOne Cancels 437,500 First Finance Warrants at $5.00 Amid Cortigent Merger Process - TradingView
Vivani Medical (VANI) to Announce Earnings on Wednesday - MarketBeat
Enterprise value to EBITDA forward of Vivani Medical, Inc. – NASDAQ:VANI - TradingView
Vivani Medical, Inc. Revenue Breakdown – NASDAQ:VANI - TradingView
Form 4 Vivani Medical Inc For: 30 July By Investing.com - Investing.com Nigeria
Vivani Medical (VANI) awards CEO 200K stock options and 100K RSUs - Stock Titan
Vivani Medical (NASDAQ: VANI) grants COO options and performance RSUs - Stock Titan
Vivani Medical (VANI) awards 70,000 options and 35,000 RSUs to CBO - Stock Titan
Form 4 Vivani Medical Inc For: 28 July By Investing.com - Investing.com Canada
Vivani Medical, Inc. (VANI) awards stock options in lieu of director fees - Stock Titan
Vivani Medical (VANI) Slides Nearly 8% as Shares Approach Key SupportCTA Positioning - dars.gov.et
Vivani Medical Market Sentiment - Benzinga España
Vivani Medical Inc. Revenue Breakdown – FWB:U5P - TradingView
Vivani Medical Inc (VANI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management - Bernama
Vivani Medical Inc (VANI) Cash Flow - TradingKey
Vivani Medical Inc (VANI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Vivani Medical Inc (VANI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Enterprise value to revenue forward of Vivani Medical, Inc. – NASDAQ:VANI - TradingView
Enterprise value to revenue forward of Vivani Medical Inc. – FWB:U5P - TradingView
Enterprise value to EBITDA forward of Vivani Medical Inc. – FWB:U5P - TradingView
ClearOne (CLRO) to acquire Cortigent, cede control to Vivani in stock deal - Stock Titan
Vivani Medical Highlights Upcoming SLIM-1 First Dosing Milestone - TipRanks
Form 4 Vivani Medical Inc For: 16 July By Investing.com - Investing.com Nigeria
Vivani Medical (NASDAQ: VANI) Targets August Human Trial For Semaglutide Implant Following Novo Nordisk Evaluation Deal - foreignpolicyjournal.com
New Form 4! Biggun at that! Hehehe - Moomoo
Vivani Medical director Gregg Williams buys $1m in stock - Investing.com UK
Vivani Medical director Gregg Williams buys $1m in stock By Investing.com - Investing.com Australia
Vivani Medical (NASDAQ: VANI) insider buys 793,650 shares at $1.26 - Stock Titan
Vivani Medical says first SLIM-1 dosing expected in August 2026 after CEO presentation - TradingView
Vivani Medical Inc Stock (VANI) Financials Data
Revenue
Net Income
Cash Flow
EPS
Vivani Medical Inc Stock (VANI) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Williams Gregg | Director |
Jun 15 '26 |
Buy |
1.26 |
1,587,301 |
1,999,999 |
36,119,086 |
| Williams Gregg | Director |
May 15 '26 |
Buy |
1.26 |
1,587,301 |
1,999,999 |
34,531,785 |
| Williams Gregg | Director |
Apr 15 '26 |
Buy |
1.26 |
1,587,301 |
1,999,999 |
32,944,484 |
| Williams Gregg | Director |
Mar 15 '26 |
Buy |
1.07 |
1,575,231 |
1,683,335 |
31,357,183 |
| Williams Gregg | Director |
Feb 15 '26 |
Buy |
1.06 |
1,866,492 |
1,983,333 |
29,781,952 |
| Williams Gregg | Director |
Jan 27 '26 |
Buy |
1.48 |
1,351,351 |
1,999,999 |
27,915,460 |
| Williams Gregg | Director |
Jan 15 '26 |
Buy |
1.14 |
1,737,765 |
1,983,334 |
26,564,109 |
| Mendelsohn Aaron | Director |
Dec 29 '25 |
Buy |
1.23 |
20,000 |
24,600 |
188,170 |
| Williams Gregg | Director |
Dec 15 '25 |
Buy |
1.14 |
1,737,765 |
1,983,334 |
24,826,344 |
| Williams Gregg | Director |
Nov 15 '25 |
Buy |
1.14 |
1,737,764 |
1,983,333 |
23,088,579 |
2.24%
1.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):